Stemtech Corp (STEK)
About Stemtech Corp
STEMTECH CORP
This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.
Financial summary
- Revenue FY2025
- $2.9M
- Net income
- -$4.0M
- Total assets
- $3.1M
Source: SEC EDGAR · updated Jun 8, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
Stemtech Corp (STEK) Stock Price
- Reported a net loss of $4.0M in FY2025.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Stemtech Corp.
Write a review
Stemtech Corp: frequently asked questions
Is Stemtech Corp an American company?
Stemtech Corp is a US-based company headquartered in Naples, Florida, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Stemtech Corp headquartered?
Stemtech Corp is headquartered in Naples, Florida, United States.
Is Stemtech Corp publicly traded?
Yes — Stemtech Corp is a publicly traded company. Its stock trades under the ticker symbol STEK on the OTC.
What does Stemtech Corp do?
Stemtech Corp is an American Pharmaceuticals company in the Health & Beauty sector.
